Repeated multi-domain cognitive training prevents cognitive decline, anxiety and amyloid pathology found in a mouse model of Alzheimer disease

Commun Biol. 2023 Nov 10;6(1):1145. doi: 10.1038/s42003-023-05506-6.

Abstract

Education, occupation, and an active lifestyle, comprising enhanced social, physical, and mental components are associated with improved cognitive functions in aged people and may delay the progression of various neurodegenerative diseases including Alzheimer's disease. To investigate this protective effect, 3-month-old APPNL-G-F/NL-G-F mice were exposed to repeated single- or multi-domain cognitive training. Cognitive training was given at the age of 3, 6, & 9 months. Single-domain cognitive training was limited to a spatial navigation task. Multi-domain cognitive training consisted of a spatial navigation task, object recognition, and fear conditioning. At the age of 12 months, behavioral tests were completed for all groups. Then, mice were sacrificed, and their brains were assessed for pathology. APPNL-G-F/NL-G-F mice given multi-domain cognitive training compared to APPNL-G-F/NL-G-F control group showed an improvement in cognitive functions, reductions in amyloid load and microgliosis, and a preservation of cholinergic function. Additionally, multi-domain cognitive training improved anxiety in APPNL-G-F/NL-G-F mice as evidenced by measuring thigmotaxis behavior in the Morris water maze. There were mild reductions in microgliosis in the brain of APPNL-G-F/NL-G-F mice with single-domain cognitive training. These findings provide causal evidence for the potential of certain forms of cognitive training to mitigate the cognitive deficits in Alzheimer disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease* / pathology
  • Alzheimer Disease* / prevention & control
  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Amyloidogenic Proteins
  • Animals
  • Anxiety / etiology
  • Anxiety / prevention & control
  • Cognitive Dysfunction* / etiology
  • Cognitive Dysfunction* / prevention & control
  • Cognitive Training
  • Humans
  • Infant
  • Mice
  • Mice, Transgenic

Substances

  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Amyloidogenic Proteins